- Home
- Publications
- Publication Search
- Publication Details
Title
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-06
DOI
10.3389/fonc.2019.00873
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Role of osteopontin in dendritic cell shaping of immune responses
- (2019) Annalisa Del Prete et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Thymosin alpha‐1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549)
- (2019) Jasmin Kharazmi‐Khorassani et al. ENVIRONMENTAL TOXICOLOGY
- Modulating inflammation for cancer therapy
- (2019) Birgit Ritter et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer
- (2018) Fanwen Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
- (2018) Mark A. Samaan et al. Nature Reviews Gastroenterology & Hepatology
- The Cancer Immunotherapy Revolution
- (2018) Priscilla N. Kelly SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Effect of a C-end rule modification on antitumor activity of thymosin α1
- (2018) Fanwen Wang et al. BIOCHIMIE
- Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy
- (2018) Riccardo Danielli et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study
- (2018) Xiaoning Wu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
- (2018) Fanwen Wang et al. Scientific Reports
- Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling
- (2018) Cong Bo et al. OncoTargets and Therapy
- Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
- (2017) Chao He et al. MEDICINE
- Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
- (2017) Luigina Romani et al. NATURE MEDICINE
- Bifidobacteriumcan mitigate intestinal immunopathology in the context of CTLA-4 blockade
- (2017) Feng Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study
- (2016) Yong-Rong Liang et al. Oncology Letters
- Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1
- (2015) Chao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis
- (2015) Robert S King et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
- (2014) Michelle N. Messmer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intracellular Osteopontin Inhibits Toll-like Receptor Signaling and Impedes Liver Carcinogenesis
- (2014) X. Fan et al. CANCER RESEARCH
- The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1–thymopentin fusion peptide and its binding to TLR2
- (2013) Juan Li et al. CANCER LETTERS
- A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
- (2013) Xingzhen Lao et al. PLoS One
- Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond
- (2012) Riccardo Danielli et al. Annals of the New York Academy of Sciences
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression, Purification and Characterization of A Novel Soluble Human Thymosin Alpha1 Concatemer Exhibited A Stronger Stimulation on Mice Lymphocytes Proliferation and Higher Anti-tumor Activity
- (2012) Weina Li et al. International Journal of Biological Sciences
- Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
- (2012) A. Ciancio et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
- (2012) Bo Hyun Kim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Thymosin plus cisplatin with vinorelbine or gemcitabine for non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
- (2011) Jin Jiang et al. Thoracic Cancer
- Intracellular osteopontin (iOPN) and immunity
- (2010) Makoto Inoue et al. IMMUNOLOGIC RESEARCH
- Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
- (2010) Michele Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
- (2009) Robert G. Gish et al. Hepatology International
- Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
- (2009) Yuan-Yuan Zhang et al. Virology Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now